Skip to content

Nurse-led Clinics Training Program on Mild Cognitive Impairment Patients

Effectiveness of Nurse-led Clinics Training Program on Mild Cognitive Impairment Patients: a Randomized Controlled Trial Protocol

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06198530
Enrollment
96
Registered
2024-01-10
Start date
2024-01-15
Completion date
2025-06-30
Last updated
2024-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Keywords

nurse-led clinics, computerized cognitive training, randomized controlled clinical trial

Brief summary

This trail is the first study to test the efficacy of nurse-led clinics cognitive training on mild cognitive impairment (MCI) patients using a single-blind, randomized controlled trial design. The investigators hypothesize that nurse-led clinics cognitive training can (a)decelerate or ameliorate cognitive decline, (b)ameliorate anxiety and depressive symptoms, (c)increase the quality of life for both patients and family members, (d)improve the ability of daily life, (e)reduce the incidence of agitation.

Detailed description

Introduction: Globally, nurse-led clinics(NLCs) have been developed to serve and follow up on patients who have just been discharged from the hospital. NLCs cognitive training program as a potentially effective and promising treatment for MCI patients. Methods: The study is a single-blind, randomized-controlled trial. Eligible patients need to be diagnosed as MCI. Participants will be randomized into either a NLCs training group or a home-based training group. Both groups will undergo total 72hour across 12 months. The outcome measures will be assessed at baseline, at the 6 months and 12 months during the intervention. The primary outcome is global cognitive function, assessed by the 30-item the Mini-Mental State Examination (MMSE), and the secondary outcomes include changes in other neuropsychological assessments and in result of resting electroencephalography (EEG) . Results: The trial is currently ongoing, and it is anticipated that recruitment will be completed in June 2025. Discussion: This trial will evaluate the efficacy and safety of NLCs cognitive training in patients with MCI, and further explore the potential mechanisms by analyzing teh results of neuropsychological assessments and EEG.

Interventions

BEHAVIORALcognitive training in NLCs

In the nurse-led clinics(NLCs) training group, CCT was given twice a week during 1-6 months and once a week during 7-12 month in nursing clinic. There is 60 minutes at a time.

BEHAVIORALcognitive training in home

In the home-based training group, CCT was given four times a week during 1-6 months and twice a week during 7-12 month in nursing clinic. There is 30 minutes at a time. Nurses teach patients to acquire and carry out CCT at home during hospitalization. Nurses set the daily reminder function at 9:00am through training system.

BEHAVIORALcognitive training in tradition

In the traditional training group, the Home Cognitive Training Manual for Alzheimer's Disease compiled by our research team was distributed.

Sponsors

Xuanwu Hospital, Beijing
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Masking description

Radiologists, statisticians, and neuropsychologists who measure the outcomes will be blinded to the randomization status. Blinding will also be maintained for data management, outcome assessment, and data analysis. Participants and therapists cannot be blinded to the intervention they receive or provide.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects with informed consent; * Literate Han Chinese, above the age of 18; * At least 6 years of education; * Neither normal nor demented according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, with a Clinical Dementia Rating(CDR) ≥0.5 on at least one domain and a global score ≤0.5; a Mini-Menta State Examination score ≥20 (primary school), or ≥24 (junior school or above). * having normal vision and hearing with/without corrective devices.

Exclusion criteria

* Severe aphasia, physical disabilities, or any other factor that might preclude completion of neuropsychological testing. * Clinically significant gastrointestinal, renal, hepatic, respiratory, infectious, endocrine, or cardiovascular system disease; cancer; alcoholism; drug addiction. * Illnesses affecting mobility or are unable to accept assessments or interventions that are required in this study.

Design outcomes

Primary

MeasureTime frameDescription
Change in Mini-Mental State Examination (MMSE)From baseline to the 6-month and 12-month after interventionThe intervention will be assessed by the MMSE in which scores range from 0 to 30, with higher scores representing better general cognitive performance.

Secondary

MeasureTime frameDescription
Change in World Health Organization-University of California-Los Angeles Auditory Verbal Learning Test (WHO-UCLA AVLT)From baseline to the 6-month and 12-month after interventionWorld Health Organization-University of California-Los Angeles Auditory Verbal Learning Test , which scores range from 0 to 45 will be used to assess memory function in which scores range from 0 to 45, with a higher value representing a better outcome.
Change in Boston Naming Test (BNT)From baseline to the 6-month and 12-month after interventionBoston Naming Test in which scores range from 0 to 30 will be used to assess language performance, specifically visual naming ability.
Change in Instrumental activities of daily living(IADL)From baseline to the 6-month and 12-month after interventionInstrumental activities of daily living in which scores range from 0 to 24 were defined as being whether able to complete Instrumental activity ability.
Change in the barthel index(BI)From baseline to the 6-month and 12-month after interventionthe barthel index in which scores range from 0 to 100 were defined as being whether able to complete basic activity ability.
Change in Hamilton Anxiety rating scale(HARS)From baseline to the 6-month and 12-month after interventionHamilton Anxiety rating scale in which scores range from 0 to 56 measures14 items, adopt Likert5 level score, the higher the score according to the more serious the degree of anxiety
Change in Montreal Cognitive Assessment (MoCA)From baseline to the 6-month and 12-month after interventionMontreal Cognitive Assessment in which scores range from 0 to 30, with higher scores representing better general cognitive performance.
Change in Cohen-Mansfield Agitation Inventory (CMAI)From baseline to the 6-month and 12-month after interventionThe Cohen-Mansfield Agitation Inventory measures 29 agitated or aggressive behaviors. The frequency of each symptom is rated on a seven-point scale (1-7) ranging from never to several times an hour.the scores range from 29 to 203. The higher the score according to the more serious the degree of agitation
Change in Neuropsychiatric Inventory(NPI)From baseline to the 6-month and 12-month after interventionThe Neuropsychiatric Inventory consists of 12 items that are assayed with questions, subquestions, and ratings of frequency and severity. the scores range from 0 to 144. The higher the score according to the more serious the degree of mental and behavioral abnormalities
Change in Zarit caregiver burden interview (ZBI)From baseline to the 6-month and 12-month after interventionZarit caregiver burden interview contains 29 items on a four-point Likert scale, will be used to assess the burden of caregivers.
Change in Resting EEGFrom baseline to the 6-month and 12-month after interventionEEG was acquired using a 32-conductor electrode cap and amplifier (BioSemi, Amsterdam, Netherlands) with a 2048-Hz sampling rate. To reduce interference during signal acquisition, we ensured that the electrode resistance was\<5 kΩ. During data collection, the participants were seated in a comfortable chair, relaxed, refrained from speech or voluntary movements, and kept their eyes closed. The eyes-closed state was recorded for 5 min, and the data were stored on a computer for offline analysis.
Change in Geriatric depression scale(GDS)From baseline to the 6-month and 12-month after interventionGeriatric depression scale measures 30 items,in which scores range from 0 to 30. The higher the score according to the more serious the degree of depression

Countries

China

Contacts

Primary Contactyuchen Qiao
qiaoyc2015@163.com01083192331

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026